ACM
ORKA

ADAR1 Capital Management’s Oruka Therapeutics ORKA Stock Holding History

ADAR1 Capital Management’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.98M Hold
20,840
– – 0.09% 141
2026
Q1 		$1.02M Hold
20,840
– – 0.06% 160
2025
Q4 		$632K Hold
20,840
– – 0.05% 173
2025
Q3 		$401K Sell
20,840
-121,940
-85% -$1.81M 0.04% 151
2025
Q2 		$1.6M Buy
142,780
+10,000
+8% +$104K 0.25% 64
2025
Q1 		$1.36M Buy
+132,780
New +$1.66M 0.25% 70
2024
Q4 		– Sell
-11,187
Closed -$274K – 315
2024
Q3 		$274K Buy
11,187
+4,131
+59% +$144K 0.04% 148
2024
Q2 		$324K Buy
+7,056
New +$281K 0.06% 123

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

ADAR1 Capital Management's ORKA Position: Q2 2026 in Review

ADAR1 Capital Management held its Oruka Therapeutics (ORKA) position steady in Q2 2026 at 20,840 shares worth $1.98M. The position accounts for 0.09% of the portfolio, ranked #141.

ADAR1 Capital Management first reported a position in ORKA in Q2 2024 and has held it in 8 quarters since. 256 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • ADAR1 Capital Management held 20,840 shares of Oruka Therapeutics worth $1.98M as of Q2 2026.
  • ADAR1 Capital Management left its Oruka Therapeutics share count unchanged in Q2 2026.
  • Oruka Therapeutics made up 0.09% of ADAR1 Capital Management's portfolio in Q2 2026, its #141 holding.
  • ADAR1 Capital Management first reported a position in Oruka Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • 256 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.